A Multiplexable, Microfluidic Platform for the Rapid Quantitation of a Biomarker Panel for Early Ovarian Cancer Detection at the Point-of-Care
Basil H. Shadfan(Rice University), John T. McDevitt(New York University), Archana R. Simmons(Rice University), Glennon W. Simmons(Rice University), Jorge Wong(The University of Texas at Austin), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Robert C. Bast(The University of Texas MD Anderson Cancer Center), Andy Ho(Rice University)
Cited by 63
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
|The Lancet|2010|2.3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k